TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT04898985

The Leukemia and Lymphoma Society (LLS) T-cells in Blood Cancer and COVID-19

Cause of deathStaffing, sites or logistics Automatic label, confidence 0.9, unverified. How labels are made.
“Recruitment was completed for initial evaluation of T-cell response to early Covid-19”

The sponsor’s own words in the registry.

Life of this trial

202120222023Registered2021-05-20Started2021-05-20Suspended (as of)2022-08-17

Vital statistics

Status
Suspended
Sponsor
Larry Saltzman, MD
Sponsor type
University, hospital or other
Conditions
Covid-19
Interventions
ImmunoSEQ
Participants
1,000 (planned, not actual)
Sites
1
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.